Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-31 Purchase |
2023-09-08 5:47 pm |
Arch Therapeutics Inc. | ARTH | Hicks Laurence Director |
10,292 | $0.275 | $2,830 | 30,876 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-31 Option Award |
2023-09-08 5:47 pm |
N/A 2028-08-31 |
Arch Therapeutics Inc. | ARTH | Hicks Laurence Director |
20,584 | $0 | 30,876 (Indirect) |
View |
| 2022-11-10 Option Award |
2022-11-10 9:51 pm |
N/A 2032-11-10 |
Arch Therapeutics Inc. | ARTH | Hicks Laurence Director |
250,000 | $0 | 250,000 (Direct) |
View |
| 2022-07-06 Option Award |
2022-07-08 4:53 pm |
N/A N/A |
Arch Therapeutics Inc. | ARTH | Hicks Laurence Director |
868,998 | $0 | 868,998 (Direct) |
View |
| 2021-09-27 Option Award |
2021-10-13 06:03 am |
N/A 2031-09-26 |
Arch Therapeutics Inc. | ARTH | Hicks Laurence Director |
250,000 | $0 | 250,000 (Direct) |
View |
Ownership |
2021-10-12 9:23 pm |
N/A N/A |
Arch Therapeutics Inc. | ARTH | Hicks Laurence Director |
0 | $0 | 527,273 (Indirect) |
View |